Vernalis
Manufacturing · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Granta Great Abington Park, Cambridge, C...Phone Number
+44 1223895555Website
www.vernalis.comRevenue
$25.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Vernalis
Vernalis is a revenue generating, commercial stage pharmaceutical company with significant expertise in drug development.Explore more
Vernalis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vernalis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Vernalis recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Vernalis launches new products
Funding: Get notified immidiatlly once Vernalis has new funding data
Congratulate Masked Content for being promoted to Masked Content at Vernalis
Check out if Vernalis is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Vernalis had a recent Job posting/layoffs
Check if Vernalis has recently received funding, and reach out quickly before it becomes old news!
Vernalis, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Vernalis as Masked Content
Find 3 more new buyers
Compare Similar Companies to Vernalis
Compare insights from companies similar to Vernalis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vernalis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vernalis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vernalis.
Vernalis Tech Stack
A closer look at the technologies used by Vernalis
Most Recent Scoops
Event
Product Marketing, Events, Sales, Food & Beverage, Hospitality, Field /Outside Sales, Field Marketing
Event
Events
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
Vernalis News & Media
Pierre Fabre Laboratories and Vernalis announce a drug discovery collaboration in oncology
CASTRES, France and CAMBRIDGE, England, Sept. 25, 2023 /PRNewswire/ -- Pierre Fabre Laboratories and Vernalis (R&D) Ltd ("Vernalis"), a fully owned subsidiary of HitGen Inc., are pleased to announce a long-term partnership to identify pre-clinical candidates against multiple oncology...Pierre Fabre Laboratories and Vernalis announce a drug discovery collaboration in oncology
CASTRES, France and CAMBRIDGE, England, Sept. 25, 2023 /PRNewswire/ -- Pierre Fabre Laboratories and Vernalis (R&D) Ltd ("Vernalis"), a fully owned subsidiary of HitGen Inc., are pleased to announce a long-term partnership to identify pre-clinical candidates against multiple oncology...Pierre Fabre Laboratories and Vernalis announce a drug discovery collaboration in oncology
CASTRES, France and CAMBRIDGE, England, Sept. 25, 2023 /PRNewswire/ -- Pierre Fabre Laboratories and Vernalis (R&D) Ltd ("Vernalis"), a fully owned subsidiary of HitGen Inc., are pleased to announce a long-term partnership to identify pre-clinical candidates against multiple oncology targets. Under the terms of the agreement, Vernalis will use its expertise to enable drug discovery against an undisclosed portfolio of targets and use fragment and structure-based methods to identify small moleculeVernalis Research, a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S announce a strategic collaboration in the field of RNA-targeting small molecules in neurology
CAMBRIDGE, England and COPENHAGEN, Denmark, Sept. 28, 2022 /PRNewswire/ -- Vernalis Research ("Vernalis"), a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S ("Contera") are pleased to announce a strategic drug discovery collaboration on an undisclosed target. Under the terms of the agreement, Vernalis and Contera will use their respective expertise in fragment and structure-based drug design and RNA-based drug development within neuroscience to design small molecules against a part
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vernalis
Sign Up For FreeTo access detailed company insights
Vernalis is a revenue generating, commercial stage pharmaceutical company with significant expertise in drug development.... Read More
